January 22, 2022

Focus on Understanding Clinical Trials and How to Identify the Right One for You

Today’s standard treatments for patients are based on previous clinical trials and it is important to think of clinical trials as a possible treatment option instead of a last resort. Novel targets and targeted agents in clinical trials showing promise in the treatment of MDS and AML will be discussed. Hear what clinical trials are all about and if they are right for you. The most promising research from the 2021 American Society of Hematology (ASH) will also be presented.

Speaker

AB

Andrew M. Brunner, MD

Our Supporters

Thank you to Taiho Oncology, Jazz Pharmaceuticals, Novartis, Bristol-Myers Squibb, and VJHemonc for supporting this initiative.

The MDS Foundation proudly partners with the following organizations

MDS AllianceKnow AMLALAN

Get in touch

Email

patientliaison@mds-foundation.org
hcp@mds-foundation.org

Phone within the US

1-(800)-637-0839

Outside the US only

1-(609)-298-1035

Address

The MDS Foundation
4573 South Broad St., Suite 150
Yardville, NJ 08620

Guide Star Platinum

A global non-profit advocacy organization, supporting patients, families and healthcare providers in the fields of MDS and its related diseases for over 30 years

© 2024 MDS Foundation. All rights reserved.